CSIMarket Company Name, Ticker, Industry, else..
 
Harmony Biosciences Holdings inc   (NASDAQ: HRMY)
Other Ticker:  
 
 

Harmony Biosciences Holdings Inc Growth Comparisons

Select each growth Category to receive further Information



HRMY Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 15.81 % 9.75 % 7.3 % 3.85 %
Q / Q Revenue Growth (Q3 MRQ) 7.29 % 3.93 % 2.76 % 0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 25.65 % 2.77 % 5.66 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 3.86 % 2.56 % 1.77 % 1.08 %
Revenue 5 Year Average Growth - 8.81 % 7.98 % 7.77 %


HRMY's Growth Comparisons in III. Quarter 2024




Harmony Biosciences Holdings Inc 's 15.81% year on year Revenue growth, has slowed-down in the third quarter 2024 to 185 millions, but outperforms the 9.75% growth in the Major Pharmaceutical Preparations industry, and 7.3% growth in the Healthcare sector. Above the average sales gains in the Healthcare and in the Major Pharmaceutical Preparations industry, helped to elevate overall market growth to 3.85%.

Comparing the company's Revenue to the second quarter results, sales were higher by 7.29% . On the yearly basis, average annual sales growth for Harmony Biosciences Holdings Inc is %, while S & P 500's including only Businesses with the third quarter 2024 earnings, average annual sales growth is 7.77% over the past five years.

HRMY Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Total
15.81 %
7.29 %


Growth Rates of HRMY's Income in the third quarter 2024


HRMY Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) -4.34 % 90.42 % 80.05 % 4.22 %
Seq. Operating Income Change (Q3 MRQ) 188.96 % 42.18 % 33.32 % -2.5 %
Y / Y Operating Income Growth (Q3 TTM) -12.11 % -32.14 % -5.83 % 9.02 %
Seq. Operating Income Growth (Q3 TTM) -1.57 % 29.44 % 19.93 % 1.36 %
Operating Income 5 Year Avg. Change - 2.84 % 6.03 % 9.17 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 19.84 % 161.72 % 285.84 % -1.75 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) 297.66 % 59.34 % 119.47 % -8.86 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) -18.66 % -1.76 % 26.31 % 8.51 %
Seq. Income from Cont. Ops. Change (Q3 TTM) 6.64 % 42.09 % 56.61 % -0.08 %
Income from Cont. Ops. 5 Year Avg. Change - -3.9 % -9.86 % 7.33 %

HRMY Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 19.84 % -39.13 % 8.01 % -6.44 %
Q / Q Net Income Growth (Q3 MRQ) 297.66 % 59.12 % 133.05 % -6.89 %
Y / Y Net Income Change (Q3 TTM) -18.66 % -41.18 % -10.96 % 4.96 %
Seq. Net Income Change (Q3 TTM) 6.64 % -26.14 % 2.56 % -1.41 %
Net Income 5 Year Avg. Growth - 4.26 % -3.49 % 7.48 %

HRMY's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 26.56 % 180.79 % 285.84 % -1.75 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) 305 % 56.64 % 119.47 % -8.86 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) -14.68 % - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) 8.6 % - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -16.94 % -9.86 % 7.33 %



HRMY EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 25.4 % -34.7 % 8.01 % -6.44 %
Q / Q EPS Net Growth (Q3 MRQ) 295 % 56.43 % 133.05 % -6.89 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) 8.18 % - - -6.16 %
EPS Net 5 Year Avg. Change - 4.26 % -3.49 % 7.48 %



Harmony Biosciences Holdings Inc showed impressive 25.4% year on year rise in the third quarter to $0.79, despite the -34.7% inMajor Pharmaceutical Preparations industry, Healthcare sector grew 8.01%. Although Major Pharmaceutical Preparations industry's earnings per share were softer then -6.44% overall market growth, Harmony Biosciences Holdings Inc and the Healthcare sector have delivered above the average market earnings per share.

The Company's sequential EPS growth rate was very impressive 295% from the second quarter. Average yearly income per share growth for Harmony Biosciences Holdings Inc is %, while S & P 500's average annual income per share growth is 7.48% over the five years, including only Businesses with the third quarter 2024 earnings results.

HRMY Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) 11.73 % 38.16 % 37.8 % -41.98 %
Seq. Free Cash Flow Change (Q3 MRQ) 65.43 % 201.6 % 107.49 % -35.8 %
Y / Y Free Cash Flow Change (Q3 TTM) 30.42 % 1 % 4.24 % 3.46 %
Seq. Free Cash Flow Change (Q3 TTM) 3.47 % 8.1 % 8.11 % -10.66 %
Free Cash Flow 5 Year Avg. Change - 11.97 % 7.07 % 11.98 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) 874.83 % - -79.59 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) 17.83 % - - -
Seq. Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - 0.02 % 10.04 % -33.52 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) - 1.99 % 1.51 % 2.82 %
Seq. Capital Expenditures Change (Q3 MRQ) -99.53 % 9.65 % 5.72 % 3.24 %
Y / Y Capital Expenditures Change (Q3 TTM) 264.39 % 5.59 % 3.04 % 69.35 %
Seq. Capital Expenditures Change (Q3 TTM) 0.4 % 1.69 % 2.03 % -0.5 %
Capital Expenditures 5 Year Avg. Change - 13.66 % 9.35 % 8.9 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com